[Extraintestinal manifestations in inflammatory bowel disease].
Extraintestinal manifestations are relatively common in chronic inflammatory bowel disease and affect joints, skin, eyes and bile ducts. The most frequent rheumatologic manifestations are peripheral arthritis and axial arthropathies. Erythema nodosum and pyoderma gangraenosum are common dermatological manifestations, while episcleritis, iridocyclitis and uveitis are common ophthalmological complications. Conventional drugs and biologicals have proven effective in the treatment of several of the manifestations, including peripheral arthritis, pyoderma gangraenosum and episcleritis.
c/o Ole Haagen Nielsen, Gastroenheden, Medicinsk Sektion, Herlev Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark. signelarsen@stud.ku.dk
Signe
S
Larsen
Klaus
K
Bendtzen
Ole Haagen
OH
Nielsen
D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy / Q000209:etiology; D001649:Bile Duct Diseases / Q000175:diagnosis / Q000209:etiology; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy; D015863:Iridocyclitis / Q000188:drug therapy / Q000209:etiology; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000209:etiology*; D015423:Scleritis / Q000188:drug therapy / Q000209:etiology; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology; D014605:Uveitis / Q000188:drug therapy / Q000209:etiology
D000893:Anti-Inflammatory Agents; D018501:Antirheumatic Agents